Cargando…

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP

Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to promote the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, He, Xilin, Wan, Yajie, Zhang, Honghong, Tang, Tao, Zhang, Meng, Yu, Shiyi, Zhao, Weiyong, Chen, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603576/ https://www.ncbi.nlm.nih.gov/pubmed/34798909 http://dx.doi.org/10.1186/s40164-021-00247-w

Ejemplares similares

ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
por: Yu, Shiyi, et al.
Publicado: (2019)

Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
por: Yu, Shiyi, et al.
Publicado: (2014)

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

A YAP/TAZ-CD54 axis is required for CXCR2(−)CD44(−) tumor-specific neutrophils to suppress gastric cancer
por: Nie, Pingping, et al.
Publicado: (2022)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

Activation of the mTOR pathway promotes neurite growth through upregulation of CD44 expression
por: Zhang, Jiwei, et al.
Publicado: (2023)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity
por: Yan, Yu-Chuan, et al.
Publicado: (2023)

Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
por: Tian, Yu, et al.
Publicado: (2016)

CD168(+) macrophages promote hepatocellular carcinoma tumor stemness and progression through TOP2A/β-catenin/YAP1 axis
por: Zhao, Hai-Chao, et al.
Publicado: (2023)

YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression
por: Jin, Lan, et al.
Publicado: (2021)

SALL4 promotes gastric cancer progression through activating CD44 expression
por: Yuan, X, et al.
Publicado: (2016)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation
por: Yang, Wenjie, et al.
Publicado: (2021)

CD44 expression in patients with combined hepatocellular cholangiocarcinoma
por: Kim, Ryounggo, et al.
Publicado: (2015)

The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression
por: Wei, Xiaolei, et al.
Publicado: (2014)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
por: Lai, Chih-Jen, et al.
Publicado: (2019)

CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine
por: Kim, Hyun Young, et al.
Publicado: (2022)

MINDY1 promotes bladder cancer progression by stabilizing YAP
por: Luo, Yongwen, et al.
Publicado: (2021)

Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44(-/-) tumor cells, MEFs and macrophages
por: Schultz, Kristin, et al.
Publicado: (2018)

YAP Activation in Promoting Negative Durotaxis and Acral Melanoma Progression
por: Huang, Yuxing, et al.
Publicado: (2022)

CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
por: Hu, Song, et al.
Publicado: (2020)

CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
por: Hao, Xiaopei, et al.
Publicado: (2022)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming
por: Liu, Yang, et al.
Publicado: (2019)

Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis
por: Li, Siyi, et al.
Publicado: (2019)

Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1
por: Wang, Jianlin, et al.
Publicado: (2019)

CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity
por: Fu, Yan, et al.
Publicado: (2022)

Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression
por: Wang, Feiran, et al.
Publicado: (2022)

The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression
por: Li, Jun, et al.
Publicado: (2020)

Extracellular HMGB1 promotes CD44 expression in hepatocellular carcinoma via regulating miR-21
por: Li, Jun, et al.
Publicado: (2021)

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma
por: Luo, Xiaoling, et al.
Publicado: (2017)

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)

CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma
por: Mao, Jiakai, et al.
Publicado: (2019)

Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
por: Gadhoum, S Z, et al.
Publicado: (2016)

CD44: A Multifunctional Mediator of Cancer Progression
por: Hassn Mesrati, Malak, et al.
Publicado: (2021)

Down-Regulation of Neogenin Accelerated Glioma Progression through Promoter Methylation and Its Overexpression in SHG-44 Induced Apoptosis
por: Wu, Xinmin, et al.
Publicado: (2012)

CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion
por: Le Bras, Grégoire F., et al.
Publicado: (2011)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmadliqk73mf47uptt1j4o0toc